How do 5-alpha-reductase inhibitors help in BPH and when is the expected improvement?

Prepare for the Urology and Nephrology Test with focused study materials. Utilize flashcards and multiple-choice questions featuring hints and explanations. Ensure your readiness for the examination.

Multiple Choice

How do 5-alpha-reductase inhibitors help in BPH and when is the expected improvement?

Explanation:
5-alpha-reductase inhibitors work by blocking the conversion of testosterone to dihydrotestosterone in the prostate. DHT drives prostatic growth, so lowering DHT reduces androgenic stimulation and leads to a gradual shrinkage of the enlarged gland. Because this is a remodeling process, the improvement in urinary symptoms and obstruction doesn’t happen right away; it typically becomes noticeable after several months, most commonly around 6 to 12 months. PSA levels also fall as the prostate size decreases, reflecting the reduced tissue volume. Therefore, the correct description is that the drug shrinks the prostate by reducing DHT, with improvement expected after about 6–12 months.

5-alpha-reductase inhibitors work by blocking the conversion of testosterone to dihydrotestosterone in the prostate. DHT drives prostatic growth, so lowering DHT reduces androgenic stimulation and leads to a gradual shrinkage of the enlarged gland. Because this is a remodeling process, the improvement in urinary symptoms and obstruction doesn’t happen right away; it typically becomes noticeable after several months, most commonly around 6 to 12 months. PSA levels also fall as the prostate size decreases, reflecting the reduced tissue volume. Therefore, the correct description is that the drug shrinks the prostate by reducing DHT, with improvement expected after about 6–12 months.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy